nakano kazuhiko

FacultyUrology
Job titleAssistant ProfessorWeb site

Research Activities

Papers(paper)

  • Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury.
    Nakano K, Ando H, Kurokawa S, Hosohata K, Ushijima K, Takada M, Tateishi M, Yonezawa A, Masuda S, Matsubara K, Inui K, Morita T, Fujimura A
    Cancer chemotherapy and pharmacology 75(6) 1191-1197 Jun. 2015
  • External validation of risk classification in patients with docetaxel-treated castration-resistant prostate cancer.
    Nakano K, Komatsu K, Kubo T, Natsui S, Nukui A, Kurokawa S, Kobayashi M, Morita T
    BMC urology 14 31 Apr. 2014
  • Hand-foot skin reaction is associated with the clinical outcome in patients with metastatic renal cell carcinoma treated with sorafenib.
    Nakano K, Komatsu K, Kubo T, Natsui S, Nukui A, Kurokawa S, Kobayashi M, Morita T
    Japanese journal of clinical oncology 43 1023-1029 Oct. 2013
  • Life-threatening acute acalculous cholecystitis in a patient with renal cell carcinoma treated by sunitinib: a case report.
    Nakano K, Suzuki K, Morita T
    Journal of medical case reports 6 69 Feb. 2012
  • Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience.
    Nakano K, Ohta S, Komatsu K, Kubo T, Nukui A, Suzuki K, Kurokawa S, Kobayashi M, Morita T
    BMC urology 12 3 Feb. 2012
Display all
Papers(paper)close
  • Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury.
    Nakano K, Ando H, Kurokawa S, Hosohata K, Ushijima K, Takada M, Tateishi M, Yonezawa A, Masuda S, Matsubara K, Inui K, Morita T, Fujimura A
    Cancer chemotherapy and pharmacology 75(6) 1191-1197 Jun. 2015
  • External validation of risk classification in patients with docetaxel-treated castration-resistant prostate cancer.
    Nakano K, Komatsu K, Kubo T, Natsui S, Nukui A, Kurokawa S, Kobayashi M, Morita T
    BMC urology 14 31 Apr. 2014
  • Hand-foot skin reaction is associated with the clinical outcome in patients with metastatic renal cell carcinoma treated with sorafenib.
    Nakano K, Komatsu K, Kubo T, Natsui S, Nukui A, Kurokawa S, Kobayashi M, Morita T
    Japanese journal of clinical oncology 43 1023-1029 Oct. 2013
  • Life-threatening acute acalculous cholecystitis in a patient with renal cell carcinoma treated by sunitinib: a case report.
    Nakano K, Suzuki K, Morita T
    Journal of medical case reports 6 69 Feb. 2012
  • Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience.
    Nakano K, Ohta S, Komatsu K, Kubo T, Nukui A, Suzuki K, Kurokawa S, Kobayashi M, Morita T
    BMC urology 12 3 Feb. 2012


Copyright c MEDIA FUSION Co.,Ltd. All rights reserved.